CBC. "The debate over HPV inoculations." 2009. Retrieved on June 25, 2010, from the Web site: http://www.cbc.ca/health/story/2009/08/19/gardasil-hpv-vaccine-explainer263.html
Haug, Charlotte J. (2008). "Human papillomavirus -- reasons for caution." The New
England Journal of Medicine, volume 359:861-862. No. 8.
Norsigian, Judy., Priest, Alice., & Barnett, Robin. (2007). "Gardasil: What you need to know about the HPV vaccine." The Canadian women's health network. Retrieved on June 22, 2010, from the Web site:
American Cancer Society. Cancer Facts & Figures, 2008. Atlanta: American Cancer Society: 2008.
Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines 2006. Morbidity and Mortality Weekly Report 2006; 55
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-9.
Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J. Med. 2007; 356(19):1928-43.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. 2007; 56: 1-24.
Pharmaceutical News (March 5, 2008) Safety of Merck's HPV Vaccine Gardasil 'Lost' in Debate. Retrieved May 23, 2008, from News-Medical.net website, at http://www.news-medical.net/?id=22415.
Taylor, C., Lillis, C., LeMone, P. (2005) Fundamentals of Nursing: The Art and Science of Nursing Care. Philadelphia: Lippincott, Williams, and Wilkins. Winer R, Hughes JP, Feng Q, et al. Consistent condom use from time of first vaginal intercourse and the risk of genital human papillomavirus infection in young women. N Engl J. Med. 2006;354:2645-2654.
Bureau of Epidemiology. Cervical Cancer in Florida. Florida Department of Health,
2005. Retrieved on October 27, 2010 from http://www.doh.state.fl.us/disease_ctrl/epi/cancer/cervic_Report.pdf
CDC. Genital HPV Infection. Fact Sheet. Centers for Disease Control and Prevention,
2010. Retrieved on October 27, 2010 from http://www.cdc.gov/std/HPV/STDFact-HPV.htm
Health Communities. Anal Cancer and HPV in Gay and Bisexual Men in Riverview Florida LGBT Health Riverview FL: HealthCommunities.com, 2010.
Retrieved on October 27, 2010 from http://local.healthcommunities.com/Anal_Cancer_and_HPV_in_Gay_and_Bixexual_Men_Riverview_FL_r1337962-Riverview_Fl.html
Peterson, Lindsay. STDs Increasing in Bay Area, Particularly Among Teens. Tampa Bay
Online, 2009. Retrieved on October 27, 2010 from http://www2.tbo.com/content/2009/feb/15/stds-increasing-bay-area-particularly-among-teens
SOPH. Microorganisms. Chapter 2. School of Public Health: University of Alabama, 2010. Retrieved on November 2, 2010 from http://www.sop.uab.edu/coursesites/biobasis/Old/Chapter%/25202
Biewenga, P., et al. (2008). Gene Expression in Early Stage Cervical Cancer. Gynecologic Oncology, 108, 520-526.
Boulet, G.A.V., et al. (2008). Human Papillomavirus in Cervical Cancer Screening: Important
Role as Biomarker. Cancer Epidemiology, Biomarkers, and Prevention, 17(4), 810-817.
Ellenson, L.H., & Wu, T.C., (2004). Focus on Endometrial and Cervical Cancer. Cancer Cell, 5,
Engin, G. (2006). Cervical Cancer: MR imaging findings before, during, and after radiation therapy. Urogenital, 16. 313-324.
Gius, D. et al. (2007). Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Research
GlaxoSmithKline. (2007). Cervical Cancer Fact Sheet. www.glaxosmithkline.com
Hu, X., et al. (2010). TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiology, Biomarkers, and Prevention, 19(3), 755-761.
Ivansson, E.L., et al. (2008). MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1, and TAP2. Genes and Immunity 9, 613-623.
Janeway, C.A. et al. (2005). Manipulation of the Immune Response. Immunobiology: 6th Edition.
Lazcano-Ponce, E. et al. (2008). Decreasing Cervical Cancer Mortality in Mexico: Effect of Papanicolaou Coverage, Birthrate, and the Importance of Diagnostic Validity of Cytology. Cancer Epidemiology, Biomarkers, and Prevention, 17(10), 2808-2817.
National Cancer Institute (2010). Cancer Advances in Focus: Cervical Cancer, www.cancer.gov
Schiller, J.T., & Lowy, D.R. (2006). Prospects for Cervical Cancer Prevention by Human
Papillomavirus Vaccination. Cancer Research, 66(21), 10229-10232.
Sreekantaiah, C., De Braekeleer, M., & Haas, O., (1991). Cytogenic Findings in Cervical
Carcinoma: A Statistical Approach. Cancer Genetics and Cytogenetics, 53, 75-81.
Steben, M., & Duarte-Franco, E. (2007). Human papillomavirus infection: Epidemiology and pathophysiology. Gynecologic Oncology, 107(2), S2-S5.
Steller, M.A. (2003). Human Papillomavirus, it's genes…and cancer vaccines. Cancer Cell,
Therman, E., Buchler, D.A., Nieminen, U., & Timonen, S. (1983). Mitotic Modifications and Aberrations in Human Cervical Cancer. Cancer Research 30(4), 185-197.
Walboomers, J.M.M. et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology, 189(1), 12-19.
Xiaoxia, H. et al. (2010). TP53, MDM2, NQO1, and Susceptibility to Cervical Cancer. Cancer Epidemiology, Biomarkers, and Prevention, 19(3), 755-761.
Yu, T., et al. (2005). The Role of Viral Integration in the Development of Cervical Cancer.
Cancer Genetics and Cytogenetics, 158, 27-34.
Zhu, X., et al. (2009). Proteomic Identification of differentially-expressed proteins in squamous cervical cancer. Gynecologic Oncology, 112, 248-256.
Zur Hausen, H. (2002). Papillomaviruses and cancer: From basic study to clinical application.
National Review of Cancer, 2, 342-350.